Inhibition of UBE2D3 Expression Attenuates Radiosensitivity of MCF-7 Human Breast Cancer Cells by Increasing hTERT Expression and Activity

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Wang, Wenbo ^a   Yang, Lei ^a   Hu, Liu ^a   Li, Fen ^a   Ren, Li ^a   Yu, Haijun ^a   Liu, Yu ^a   Xia, Ling ^a   Lei, Han ^a   Liao, Zhengkai ^a   Zhou, Fuxiang ^a   Xie, Conghua ^a   Zhou, Yunfeng ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN D1; SHORT HAIRPIN RNA; TELOMERASE REVERSE TRANSCRIPTASE; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN CONJUGATING ENZYME E2D3; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM;

CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; FEMALE; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE LIBRARY; HUMANS; RADIATION TOLERANCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TELOMERASE; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN-CONJUGATING ENZYMES;

EID: 84878577452     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064660     Document Type: Article

References (36)

1. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, et al. (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362: 513-520.
2. Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, et al. (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25: 3259-3265.
3. Kaye JA, Melo JA, Cheung SK, Vaze MB, Haber JE, et al. (2004) DNA breaks promote genomic instability by impeding proper chromosome segregation. Curr Biol 14: 2096-2106.
4. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015.
5. Shay JW, Bacchetti S, (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791.
6. Shay JW, Keith WN, (2008) Targeting telomerase for cancer therapeutics. Br J Cancer 98: 677-683.
7. Kirkpatrick KL, Clark G, Ghilchick M, Newbold RF, Mokbel K, (2003) hTERT mRNA expression correlates with telomerase activity in human breast cancer. Eur J Surg Oncol 29: 321-326.
8. Mansfield L, Subramanian A, Devalia H, Jiang W, Newbold RF, et al. (2007) HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR. Anticancer Res 27: 2265-2268.
9. Bouffler SD, (1998) Involvement of telomeric sequences in chromosomal aberrations. Mutat Res 404: 199-204.
10. Kurvinen K, Rantanen V, Syrjanen S, Johansson B, (2006) Radiation-induced effects on telomerase in gynecological cancer cell lines with different radiosensitivity and repair capacity. Int J Radiat Biol 82: 859-867.
11. Zhou FX, Liao ZK, Dai J, Xiong J, Xie CH, et al. (2007) Radiosensitization effect of zidovudine on human malignant glioma cells. Biochem Biophys Res Commun 354: 351-356.
12. Ji XM, Xie CH, Fang MH, Zhou FX, Zhang WJ, et al. (2006) Efficient inhibition of human telomerase activity by antisense oligonucleotides sensitizes cancer cells to radiotherapy. Acta Pharmacol Sin 27: 1185-1191.
13. Li S, Crothers J, Haqq CM, Blackburn EH, (2005) Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. J Biol Chem 280: 23709-23717.
14. Inderberg-Suso EM, Trachsel S, Lislerud K, Rasmussen AM, Gaudernack G, (2012) Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001. Oncoimmunology 1: 670-686.
15. Finley D, Ciechanover A, Varshavsky A (2004) Ubiquitin as a central cellular regulator. Cell 116: S29-32,22 p following S32.
16. Hershko A, Ciechanover A, (1998) The ubiquitin system. Annu Rev Biochem 67: 425-479.
17. Jiang X, Chen ZJ, (2012) The role of ubiquitylation in immune defence and pathogen evasion. Nat Rev Immunol 12: 35-48.
18. Zhang XD, Matunis MJ, (2005) Ub in charge: regulating E2 enzyme nuclear import. Nat Cell Biol 7: 12-14.
19. Moll UM, Petrenko O, (2003) The MDM2-p53 interaction. Mol Cancer Res 1: 1001-1008.
20. Feng L, Chen J, (2012) The E3 ligase RNF8 regulates KU80 removal and NHEJ repair. Nat Struct Mol Biol 19: 201-206.
21. Wang X, Zha M, Zhao X, Jiang P, Du W, et al. (2013) Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase. Nat Commun 4: 1551.
22. Sawant SG, Gregoire V, Dhar S, Umbricht CB, Cvilic S, et al. (1999) Telomerase activity as a measure for monitoring radiocurability of tumor cells. FASEB J 13: 1047-1054.
23. Chen M, Gu J, Xing J, Spitz MR, Wu X, (2007) Irradiation-induced telomerase activity and the risk of lung cancer: a pilot case-control study. Cancer 109: 1157-1163.
24. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, et al. (1995) Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711-3715.
25. Zhong YH, Liao ZK, Zhou FX, Xie CH, Xiao CY, et al. (2008) Telomere length inversely correlates with radiosensitivity in human carcinoma cells with the same tissue background. Biochem Biophys Res Commun 367: 84-89.
26. Leteurtre F, Li X, Gluckman E, Carosella ED, (1997) Telomerase activity during the cell cycle and in gamma-irradiated hematopoietic cells. Leukemia 11: 1681-1689.
27. Oh ST, Kyo S, Laimins LA, (2001) Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. J Virol 75: 5559-5566.
28. Xiong J, Sun WJ, Wang WF, Liao ZK, Zhou FX, et al. (2012) Novel, chimeric, cancer-specific, and radiation-inducible gene promoters for suicide gene therapy of cancer. Cancer 118: 536-548.
29. Wu K, Kovacev J, Pan ZQ, (2010) Priming and extending: a UbcH5/Cdc34 E2 handoff mechanism for polyubiquitination on a SCF substrate. Mol Cell 37: 784-796.
30. Saville MK, Sparks A, Xirodimas DP, Wardrop J, Stevenson LF, et al. (2004) Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo. J Biol Chem 279: 42169-42181.
31. Okamoto Y, Ozaki T, Miyazaki K, Aoyama M, Miyazaki M, et al. (2003) UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Res 63: 4167-4173.
32. Hattori H, Zhang X, Jia Y, Subramanian KK, Jo H, et al. (2007) RNAi screen identifies UBE2D3 as a mediator of all-trans retinoic acid-induced cell growth arrest in human acute promyelocytic NB4 cells. Blood 110: 640-650.
33. Mittal MK, Singh K, Misra S, Chaudhuri G, (2011) SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination. J Biol Chem 286: 469-479.
34. Smith LL, Coller HA, Roberts JM, (2003) Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 5: 474-479.
35. Diehl JA, Zindy F, Sherr CJ, (1997) Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 11: 957-972.
36. Shimura T, Kakuda S, Ochiai Y, Nakagawa H, Kuwahara Y, et al. (2010) Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression. Oncogene 29: 4826-4837.